<DOC>
	<DOCNO>NCT01284738</DOCNO>
	<brief_summary>The result allow u evaluate role MP thrombo-embolic risk observe thalassemic patient underline possible difference TM TI . The vitro vivo study MP erythrocytes concentrate new approach explore consequence transfusion polytransfused patient . Finally , identification possible relationship oxidative stress production MP may lead development specific therapeutical approach</brief_summary>
	<brief_title>Beta-thalassemia Microparticles</brief_title>
	<detailed_description>Microparticles ( MP ) intact vesicle derive cell membrane arise mainly cell membrane activation process apoptosis . MP originate platelet , endothelial cell monocytes extensively study , though similar particle arise red cell granulocyte . The ability form microparticles essential part physiological coagulation.However , MP may play important procoagulant role several disease include sickle cell disease , paroxysmal nocturnal haemoglobinuria ( PNH ) . Several study report presence MP TI potential role hypercoagulable state . The investigator propose study investigate presence origin MP TM patient .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<criteria>Patient record national register patient attain betathalassemia ( TI ) ( TM ) Patient monitor one 5 recruiter center Patient 15 year Patient consent informed Blood transfusion date less 3 month TI Composite Heterozygotes HbE /betathalassemia pregnant woman disease</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>TM</keyword>
	<keyword>TI</keyword>
	<keyword>MP</keyword>
</DOC>